Bruce Gil

Paramount Global is set to report its first quarter earnings after the bell as it's in final talks with Skydance Media for a merger

The Dutch medical device maker said it has agreed to pay $1.1 billion to settle personal injury claims related to its recalled sleep apnea machines

The FDA says three doses of the drug are still in limited availability due to an increase in demand

Novo Nordisk and Eli Lilly are selling drugs to help people drop weight, but many are gaining the weight back and some are suffering concerning health problems

The federal agency said that improper listings 'can delay cheaper generic alternatives from entering the market'

The pharmaceutical company is expected to report growing drug sales of its popular Ozempic and Wegovy medications

The Danish Medicines Agency will only offer subsidies for GLP-1 drugs, like Ozempic, for patients who can't be treated by cheaper diabetes medications

"We believe that what we have done is appropriate," said Chief Financial Officer Karsten Munk Knudsen

It's Apollo Global Management's second offer for the media giant, which has been in merger talks with Skydance

Amgen stock picked up , a day after its CEO Robert Bradway teased encouraging trial results of its experimental weight loss drug MariTide.